China NT Pharma Group Co Ltd 01011
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$0.41
- Day Range
- HK$0.41–0.41
- 52-Week Range
- HK$0.30–1.00
- Bid/Ask
- HK$0.36 / HK$0.41
- Shares Outstanding
- 1.80B
- Market Cap
- HK$736.59M
- Volume/Avg
- 10,000 / 297,467
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 32
- Website
- https://www.ntpharma.com
Valuation
|
Metric
|
01011
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 7.67 |
Price/Cash Flow | — |
Price/Earnings
01011
Financial Strength
|
Metric
|
01011
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.05 |
Interest Coverage | 0.01 |
Quick Ratio
01011
Profitability
|
Metric
|
01011
|
|---|---|
Return on Assets (Normalized) | −8.92% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −11.13% |
Return on Assets
01011
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|W^sgsFF | LOCK|^% | $245B | |||
| Danaher Corp
DHR
| LOCK|#L<??$?V | LOCK|R&$ | $156B | |||
| Agilent Technologies Inc
A
| LOCK|T?RxmvL | LOCK|fHr | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|c>z%N<z | LOCK|>Nm?m | $43B | |||
| Waters Corp
WAT
| LOCK|@!<$V@ | LOCK|xRH | $42B | |||
| Illumina Inc
ILMN
| LOCK|#K>fY? | LOCK|t<&Vh | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|!Bq><<Z | LOCK|b!D | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|#yj<^>>^ | LOCK|R!jR | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|!jw@v^r | LOCK|#fD!Z | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|g@MmCLy | LOCK|!!>Cb | $26B |
United States